Besties Regeneron, Sanofi Show Off Phase II Skin Cancer Data Post author:Sam Post published:December 12, 2017 Post category:BioPharma The positive results are spurring the companies to begin seeking approval for the checkpoint inhibitor. Source: BioSpace You Might Also Like What You Need to Know About Hyalex Orthopaedics January 10, 2018 <b>Ann Romney</b> Opens Day Three Of The BIO International Convention With A Keynote Session June 21, 2017 Cellular Biomedicine Group Plans Grand Opening Of Its New Shanghai Facility September 21, 2017
<b>Ann Romney</b> Opens Day Three Of The BIO International Convention With A Keynote Session June 21, 2017